Neuland Laboratories Ltd. (IN:NEULANDLAB)
:NEULANDLAB
Total Valuation
Neuland Laboratories Ltd. has a market cap or net worth of ₹159.53B. The enterprise value is ₹161.75B.
Market Cap₹159.53B
Enterprise Value₹161.75B
Share Statistics
Neuland Laboratories Ltd. has 12,829,889 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding12,829,889
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Neuland Laboratories Ltd.’s return on equity (ROE) is 0.17 and return on invested capital (ROIC) is 11.36%.
Return on Equity (ROE)0.17
Return on Assets (ROA)0.12
Return on Invested Capital (ROIC)11.36%
Return on Capital Employed (ROCE)0.16
Revenue Per Employee8.73M
Profits Per Employee2.11M
Employee Count1,643
Asset Turnover0.66
Inventory Turnover1.95
Valuation Ratios
The current PE Ratio of Neuland Laboratories Ltd. is 120.0. Neuland Laboratories Ltd.’s PEG ratio is -4.25.
PE Ratio120.0
PS Ratio10.27
PB Ratio9.66
Price to Fair Value9.66
Price to FCF132.83
Price to Operating Cash Flow-434.09
PEG Ratio-4.25
Income Statement
In the last 12 months, Neuland Laboratories Ltd. had revenue of 14.34B and earned 2.60B in profits. Earnings per share was 202.74.
Revenue14.34B
Gross Profit6.84B
Operating Income2.67B
Pretax Income3.46B
Net Income2.60B
EBITDA4.18B
Earnings Per Share (EPS)202.74
Cash Flow
In the last 12 months, operating cash flow was -367.47M and capital expenditures -1.71B, giving a free cash flow of -2.07B billion.
Operating Cash Flow-367.47M
Free Cash Flow-2.07B
Free Cash Flow per Share-161.73
Dividends & Yields
Neuland Laboratories Ltd. pays an annual dividend of ₹12, resulting in a dividend yield of 0.08%
Dividend Per Share₹12
Dividend Yield0.08%
Payout Ratio7.70%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.89
52-Week Price Change8.70%
50-Day Moving Average12.90K
200-Day Moving Average14.32K
Relative Strength Index (RSI)48.28
Average Volume (3m)2.41K
Important Dates
Neuland Laboratories Ltd. upcoming earnings date is May 12, 2026, TBA (Confirmed).
Last Earnings DateFeb 9, 2026
Next Earnings DateMay 12, 2026
Ex-Dividend Date―
Financial Position
Neuland Laboratories Ltd. as a current ratio of 2.45, with Debt / Equity ratio of 16.33%
Current Ratio2.45
Quick Ratio1.62
Debt to Market Cap<0.01
Net Debt to EBITDA0.06
Interest Coverage Ratio32.13
Taxes
In the past 12 months, Neuland Laboratories Ltd. has paid 862.21M in taxes.
Income Tax862.21M
Effective Tax Rate0.25
Enterprise Valuation
Neuland Laboratories Ltd. EV to EBITDA ratio is 35.34, with an EV/FCF ratio of 133.06.
EV to Sales10.29
EV to EBITDA35.34
EV to Free Cash Flow133.06
EV to Operating Cash Flow46.50
Balance Sheet
Neuland Laboratories Ltd. has ₹1.80B in cash and marketable securities with ₹2.65B in debt, giving a net cash position of -₹848.70M billion.
Cash & Marketable Securities₹1.80B
Total Debt₹2.65B
Net Cash-₹848.70M
Net Cash Per Share-₹66.15
Tangible Book Value Per Share₹966.87
Margins
Gross margin is 47.93%, with operating margin of 18.58%, and net profit margin of 18.13%.
Gross Margin47.93%
Operating Margin18.58%
Pretax Margin24.14%
Net Profit Margin18.13%
EBITDA Margin29.12%
EBIT Margin24.55%
Analyst Forecast
The average price target for Neuland Laboratories Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast0.34%
EPS Growth Forecast-14.13%